Synapsoft logo
AI Insights from Disclosures
Searching...
SK Bioscience Co.,Ltd 302440
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
SK Bioscience Co.,Ltd was established on July 1, 2018 through a spin-off, based on the capabilities accumulated as the vaccine business division within SK Chemicals. Under its mission to promote human health from prevention to treatment, the company has built its own vaccine portfolio and continuously pursued global projects, accelerating its performance. In particular, through a two-track strategy of global vaccine C(D)MO and in-house vaccine development, the company successfully responded to the COVID-19 pandemic, building a high level of capability and network in the vaccine field.
Representative Director Ahn Jaeyong
Founded July 1, 2018
Corporation Type KOSPI
Industry Classification Manufacture of medicinal chemicals
Corporate number 13111-0523736
Business number 818-86-00991
Phone Number 032-209-5000
Fax Number 02-2008-2739
Company Address 38 Yeongudanji-ro, Yeonsu-gu, Incheon
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant